Adial Pharmaceuticals Cash Flow Statement 2016-2024 | ADIL

Fifteen years of historical annual cash flow statements for Adial Pharmaceuticals (ADIL).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019201820172016
$-7.00$-10.80$-19.42$-10.89$-8.59$-11.63$-1.14$-0.42
$0.00$0.00$0.06$0.00$0.00$0.35$0.10$0.00
$0.99$0.78$5.95$2.01$2.04$9.63$0.21$0.15
$0.99$0.78$6.01$2.01$2.04$9.98$0.31$0.15
$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0
$-0.02$0.05$0.30$-0.45$-0.07$-0.81$0.01$0.01
$-0.79$-1.17$1.46$0.64$0.21$-0.85$0.34$-0.01
$-6.81$-11.19$-11.95$-7.63$-6.34$-2.50$-0.49$-0.27
$0$0$-0.06$0$0$0$0$0
$0$0$0$0$0$0$0$0
$1.50$0$0.03$0$0$0$0$0
$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0
$0$0$0$-0.35$0$0$0.04$0
$1.50$0$-0.03$-0.35$0$0$0.04$0
$0$0$0$0$0$0$0$0
$0$0$11.75$0$0$-0.08$0.35$0.20
$0$0$11.75$0$0$-0.08$0.35$0.20
$4.13$9.13$1.89$5.61$9.25$6.42$0.04$0
$4.13$9.13$1.89$5.61$9.25$6.42$0.04$0
$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0
$4.13$9.13$13.64$5.61$9.25$6.35$0.39$0.20
$-1.17$-2.06$1.66$-2.38$2.91$3.85$-0.07$-0.07
$1.75$3.37$4.24$2.01$1.60$5.37$0.21$0.15
$0$0$0$0$0$0$0$0